Dudediligence.

Estrella Immunopharma, Inc

ESLANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Listing noticeSep 8 →InsidersNo open-market buys or sales.→HoldersArmistice Capital 9.1%Vanguard 1.0%Geode 0.3%→Financing →

From the filings

Figures

Net income
−$10.0Mlast 12 months
Operating cash flow
−$8.0Mlast 12 months
Cash and equivalents
$100,000at the last balance sheet
Shares outstanding
43.5M shareson issue
Every year and quarter →